Patents Assigned to NeuroVigil, Inc.
  • Publication number: 20250082240
    Abstract: The present disclosure relates to methods and system for acquiring and analyzing biosignals or physiological signals of a person sitting in a vehicle and predicting (in real-time) time-varying attention, engagement level or alertness level using the biosignals. The biosignals may be acquired using one or more clusters of electrodes together with a wearable user device or from a sensing device that is embedded in the seat of the vehicle. In some embodiments, the biosignals may be utilized to predict restedness level of the subject, to monitor or predict physiological state of the subject, to detect a distress situation and to adapt a vehicle control accordingly. In some other embodiments, the biosignals can be transformed into communication, for example, speech signals or instructions for the vehicle. One or more actions may be triggered based on the analysis of the biosignals including engaging the person, generating alerts, or adapting the vehicle control.
    Type: Application
    Filed: September 9, 2024
    Publication date: March 13, 2025
    Applicant: NEUROVIGIL, INC.
    Inventor: Philip Low
  • Patent number: 11696724
    Abstract: Traditional analysis of sleep patterns requires several channel of data. This analysis can be useful for customized analysis including assessing sleep quality, detecting pathological conditions, determining the effect of medication on sleep states and identifying biomarkers, and drug dosages or reactions.
    Type: Grant
    Filed: June 14, 2019
    Date of Patent: July 11, 2023
    Assignee: NEUROVIGIL, INC.
    Inventor: Philip S. Low
  • Patent number: 11672459
    Abstract: The present disclosure provides a device with electrodes configured to record electrical activity that are confined to a restricted area, using recorded biological electrical signals to control cursor position in a speech-assistance interface, and using recorded biological signals to detect arousals during sleep.
    Type: Grant
    Filed: October 14, 2014
    Date of Patent: June 13, 2023
    Assignee: NEUROVIGIL, INC.
    Inventor: Philip Low
  • Patent number: 9820663
    Abstract: Methods of analysis to extract and assess brain data collected from subject animals, including humans, to detect intentional and unintentional brain activity and other unexpected signals are disclosed. These signals are correlated to higher cognitive brain functions or unintended, potentially adverse events, such as a stroke or seizure, and to translation of those signals into defined trigger events or tasks.
    Type: Grant
    Filed: June 13, 2016
    Date of Patent: November 21, 2017
    Assignee: NeuroVigil, Inc.
    Inventor: Philip Steven Low
  • Publication number: 20160256067
    Abstract: The present disclosure provides a device with electrodes configured to record electrical activity that are confined to a restricted area, using recorded biological electrical signals to control cursor position in a speech-assistance interface, and using recorded biological signals to detect arousals during sleep.
    Type: Application
    Filed: October 14, 2014
    Publication date: September 8, 2016
    Applicant: Neurovigil, Inc.
    Inventor: Philip Low
  • Patent number: 9364163
    Abstract: Methods of analysis to extract and assess brain data collected from subject animals, including humans, to detect intentional and unintentional brain activity and other unexpected signals are disclosed. These signals are correlated to higher cognitive brain functions or unintended, potentially adverse events, such as a stroke or seizure, and to translation of those signals into defined trigger events or tasks.
    Type: Grant
    Filed: January 24, 2013
    Date of Patent: June 14, 2016
    Assignee: NeuroVigil, Inc.
    Inventor: Philip Steven Low
  • Publication number: 20140031711
    Abstract: Methods of analysis to extract and assess brain data collected from subject animals, including humans, to detect intentional and unintentional brain activity and other unexpected signals are disclosed. These signals are correlated to higher cognitive brain functions or unintended, potentially adverse events, such as a stroke or seizure, and to translation of those signals into defined trigger events or tasks.
    Type: Application
    Filed: January 24, 2013
    Publication date: January 30, 2014
    Applicant: NeuroVigil, Inc.
    Inventor: NeuroVigil, Inc.